These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 981119)

  • 1. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
    Burnett D; Moore B; Williams JG; Studd JW; Bradwell AR
    Postgrad Med J; 1976; 52 Suppl 6():48-51. PubMed ID: 981119
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of sequential mestranol-norethisterone on the circulating lipid levels of pre- and post-menopausal women, and its possible significance.
    Magnani HN; Moore B
    Postgrad Med J; 1976; 52 Suppl 6():55-9. PubMed ID: 981121
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the climacteric and sequential mestranol and norethisterone on the cervix and genital tract.
    Paterson ME; Allen J; Jordan JA
    Br J Obstet Gynaecol; 1982 Aug; 89(8):657-64. PubMed ID: 7104258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy associated alpha2-glycoprotein in post-menopausal women receiving hormone replacement therapy.
    Sturdee DW; Burnett D; Moore B; Bradwell AR
    Clin Chim Acta; 1976 Oct; 72(2):233-39. PubMed ID: 975579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroendocrinologic study of depressive disorders--with special reference to gonadal functions].
    Koshikawa N; Tatsunuma T; Kawano T; Somemura K; Doi M; Seki K; Furuya K; Ikemoto Y
    Seishin Shinkeigaku Zasshi; 1989; 91(9):622-7. PubMed ID: 2516333
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose tolerance and hormone replacement therapy. A preliminary study.
    Sturdee DW; Gustafson RC; Moore B
    Postgrad Med J; 1976; 52 Suppl 6():52-4. PubMed ID: 981120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome].
    Roll H; Breckwoldt M; Amann K
    Arch Gynecol; 1979 Jul; 228(1-4):575-6. PubMed ID: 485482
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters.
    Paterson ME
    Maturitas; 1982 Aug; 4(2):83-94. PubMed ID: 6750325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1984 Jan; 63(1):12-4. PubMed ID: 6228751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of Sophia-A, combined low-dosage preparation of norethisterone and mestranol].
    Akasu F; Akasofu K; Hayashi I; Fujii I; Shimada H
    Horumon To Rinsho; 1969 Oct; 17(10):871-5. PubMed ID: 5390548
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of menopausal status and sequential mestranol and norethisterone on serum biochemical profiles.
    Moore B; Paterson ME; Sturdee DW; Whitehead TP
    Br J Obstet Gynaecol; 1981 Aug; 88(8):853-8. PubMed ID: 7260006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conception in the resistant ovary syndrome occurring during hormone replacement therapy: a report of 2 cases.
    Jequier AM
    Aust N Z J Obstet Gynaecol; 1990 May; 30(2):176-8. PubMed ID: 2400366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical results and problems of oral contraceptives, a combination of norethindrone and mestranol (2)].
    Ueda Y; Hayashi K; Maruo M; Fujii O; Yagi T
    Saishin Igaku; 1965 Dec; 20(12):3234-53 passim. PubMed ID: 5869520
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)].
    Karasawa Y
    Sanfujinka No Jissai; 1968 Oct; 17(10):913-8. PubMed ID: 5755772
    [No Abstract]   [Full Text] [Related]  

  • 16. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations].
    Göretzlehner G; Wilken H
    Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactation inhibition by norethindrone with mestranol.
    Nickerson CW; Berkman VO
    Rocky Mt Med J; 1967 Jun; 64(6):53-4. PubMed ID: 6044157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effectiveness of norethindrone-mestranol in dysfunctional uterine bleeding].
    Reyes Ceja L; Zarate A; Guerrero A
    Ginecol Obstet Mex; 1968 Jan; 23(135):103-7. PubMed ID: 5674323
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic utility of norethindrone-mestranol in abnormal uterine bleeding.
    McDonough PG; Greenblatt RB
    Obstet Gynecol; 1966 Apr; 27(4):480-3. PubMed ID: 5907368
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S; Carranza-Lira S; Celis-Gonzalez C; Santoyo S; Murillo A; Martinez N; Santos J; Llaca V; de la Loza FR; Zarain J; da Fonseca AM; Camargos AF; Baracat EC; da Sá MF; Bayo J; Adaro L; Gurucharri C; Murga M; Siseles N; Sayegh F; Tempone A; Tempone LM; Tozzini RI; Boccanera R; Naranjo C; Sanchez F; Gomez G; Blanco S; Reyes-Marquez R; Albrecht G; Rios PC
    Maturitas; 2005 Mar; 50(3):189-95. PubMed ID: 15734600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.